These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9883909)

  • 1. Kinetic properties and stereospecificity of the monomeric dUTPase from herpes simplex virus type 1.
    Bergman AC; Nyman PO; Larsson G
    FEBS Lett; 1998 Dec; 441(2):327-30. PubMed ID: 9883909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dUTPases from herpes simplex virus type 1 and mouse mammary tumour virus are less specific than the Escherichia coli enzyme.
    Björnberg O; Nyman PO
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3107-11. PubMed ID: 9000104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. dUTPase from the retrovirus equine infectious anemia virus: specificity, turnover and inhibition.
    Nord J; Larsson G; Kvassman JO; Rosengren AM; Nyman PO
    FEBS Lett; 1997 Sep; 414(2):271-4. PubMed ID: 9315700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mercury (II) compounds on the activity of dUTPases from various sources.
    Williams MV
    Mol Pharmacol; 1986 Mar; 29(3):288-92. PubMed ID: 3005836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic characterization of dUTPase from Escherichia coli.
    Larsson G; Nyman PO; Kvassman JO
    J Biol Chem; 1996 Sep; 271(39):24010-6. PubMed ID: 8798636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
    Harris JM; McIntosh EM; Muscat GE
    J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient kinetics of ligand binding and role of the C-terminus in the dUTPase from equine infectious anemia virus.
    Nord J; Kiefer M; Adolph HW; Zeppezauer MM; Nyman PO
    FEBS Lett; 2000 Apr; 472(2-3):312-6. PubMed ID: 10788633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic properties and inhibition of the dimeric dUTPase-dUDPase from Campylobacter jejuni.
    Musso-Buendía JA; Vidal AE; Kasinthan G; Nguyen C; Carrero-Lérida J; Ruiz-Pérez LM; Wilson K; Johansson NG; Gilbert IH; González-Pacanowska D
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):111-6. PubMed ID: 18608754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. dUTPase from the retrovirus equine infectious anemia virus: high-level expression in Escherichia coli and purification.
    Bergman AC; Björnberg O; Nord J; Rosengren AM; Nyman PO
    Protein Expr Purif; 1995 Jun; 6(3):379-87. PubMed ID: 7663176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2'-deoxyuridine 5'-(alpha,beta-imido) triphosphate: a substrate analogue and potent inhibitor of dUTPase.
    Persson T; Larsson G; Nyman PO
    Bioorg Med Chem; 1996 Apr; 4(4):553-6. PubMed ID: 8735843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of deoxyuridine 5'-triphosphate nucleotidohydrolase from Trypanosoma cruzi.
    Bernier-Villamor V; Camacho A; Hidalgo-Zarco F; Pérez J; Ruiz-Pérez LM; González-Pacanowska D
    FEBS Lett; 2002 Aug; 526(1-3):147-50. PubMed ID: 12208522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of homotrimeric dUTPases by the 3'-azido derivative of dideoxy-UTP.
    Palmén LG; Kvassman JO
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):146-50. PubMed ID: 19761402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and mutational studies of equine infectious anemia virus dUTPase.
    Shao H; Robek MD; Threadgill DS; Mankowski LS; Cameron CE; Fuller FJ; Payne SL
    Biochim Biophys Acta; 1997 May; 1339(2):181-91. PubMed ID: 9187238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic properties and inhibition of the dimeric dUTPase-dUDPase from Leishmania major.
    Hidalgo-Zarco F; Camacho AG; Bernier-Villamor V; Nord J; Ruiz-Pérez LM; González-Pacanowska D
    Protein Sci; 2001 Jul; 10(7):1426-33. PubMed ID: 11420444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic properties and specificity of trimeric Plasmodium falciparum and human dUTPases.
    Quesada-Soriano I; Casas-Solvas JM; Recio E; Ruiz-Pérez LM; Vargas-Berenguel A; González-Pacanowska D; García-Fuentes L
    Biochimie; 2010 Feb; 92(2):178-86. PubMed ID: 19879316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a herpes simplex virus type 2 deoxyuridine triphosphate nucleotidohydrolase and mapping of a gene conferring type specificity for the enzyme.
    Williams MV; Parris DS
    Virology; 1987 Feb; 156(2):282-92. PubMed ID: 3027979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double role for a strictly conserved serine: further insights into the dUTPase catalytic mechanism.
    Palmén LG; Becker K; Bülow L; Kvassman JO
    Biochemistry; 2008 Jul; 47(30):7863-74. PubMed ID: 18597482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the Escherichia coli dUTPase in complex with a substrate analogue (dUDP).
    Larsson G; Svensson LA; Nyman PO
    Nat Struct Biol; 1996 Jun; 3(6):532-8. PubMed ID: 8646539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminus of dUTPase: observation on flexibility using NMR.
    Nord J; Nyman P; Larsson G; Drakenberg T
    FEBS Lett; 2001 Mar; 492(3):228-32. PubMed ID: 11257499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific derivatization of the active site tyrosine in dUTPase perturbs ligand binding to the active site.
    Vertessy BG; Persson R; Rosengren AM; Zeppezauer M; Nyman PO
    Biochem Biophys Res Commun; 1996 Feb; 219(2):294-300. PubMed ID: 8604980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.